摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,3-dihydro-4-(4-methoxybenzoyl)-2H-imidazol-2-one | 83167-08-2

中文名称
——
中文别名
——
英文名称
1,3-dihydro-4-(4-methoxybenzoyl)-2H-imidazol-2-one
英文别名
4-(4-Methoxybenzoyl)-1,3-dihydroimidazol-2-one
1,3-dihydro-4-(4-methoxybenzoyl)-2H-imidazol-2-one化学式
CAS
83167-08-2
化学式
C11H10N2O3
mdl
——
分子量
218.212
InChiKey
OLPHVVYQJSUSSV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.7
  • 重原子数:
    16
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.09
  • 拓扑面积:
    67.4
  • 氢给体数:
    2
  • 氢受体数:
    3

反应信息

  • 作为产物:
    描述:
    1,3-二氢咪唑-2-酮对甲氧基苯甲酰氯三氯化铝 作用下, 以 硝基苯 为溶剂, 反应 6.0h, 以19%的产率得到1,3-dihydro-4-(4-methoxybenzoyl)-2H-imidazol-2-one
    参考文献:
    名称:
    4-Aroyl-1,3-dihydro-2H-imidazol-2-ones, a new class of cardiotonic agents
    摘要:
    A series of 4-aroyl-1,3-dihydro-2H-imidazol-2-ones was synthesized and evaluated for pharmacological activity in the anesthetized dog. Most members of this series produced dose-related increases in cardiac contractile force as well as relatively minor increases in heart rate and decreases in systemic arterial blood pressure that were not blocked by propranolol. In general, 4-methoxy or 4-methylthiobenzoyl substitution afforded compounds of greatest inotropic potency. 1,3-Dihydro-4-(4-methoxybenzoyl)-5-methyl-2H-imidazol-one (6) was shown to produce a dose-related positive inotropic effect and reverse the depressant effect of pentobarbital on cardiac pump function in the dog heart-lung preparation. The cardiotonic activity of this series may have important utility in the treatment of congestive heart failure. 1,3-Dihydro-4-[4-(methylthio)benzoyl]-5-methyl-2H-imidazol-2-one (17) was chosen for human studies and is currently undergoing clinical trials.
    DOI:
    10.1021/jm00354a017
点击查看最新优质反应信息

文献信息

  • Novel 4-aroylimidazol-2-ones
    申请人:MERRELL DOW PHARMACEUTICALS INC.
    公开号:EP0058435A2
    公开(公告)日:1982-08-25
    Novel 4-aroylimidazol-2-ones of the following general structure which are useful as antihypertensives, cardiotonics and antithrombotics wherein Ar is 2-furyl, 2-thienyl or phenyl, the latter of which may optionally be substituted with one or two X groups; X is halogen, hydroxy, C1-4 alkyl, C1-4 alkoxy, methylenedioxy, C1-4 alkylthio, C1-4 alkylsulfoxide, C1-4 alkylsufone, CF3, -SO2N(R2)2, NR3R4, pyrrolidino, piperidino, morpholino, piperazino or N'-alkyl-piperazino, R is hydrogen, C1-4 alkyl, C1-4 alkylcarbonyl or benzyl; each of R1, R2, R3 and R4 are hydrogen or C1-4 alkyl; and the pharmaceutically acceptable salts thereof.
    具有以下一般结构的新型 4-芳基咪唑-2-酮,可用作抗高血压药、强心剂和抗血栓药 其中 Ar 是 2-呋喃基、2-噻吩基或苯基,后者可任选被一个或两个 X 基团取代;X 是卤素、羟基、C1-4 烷基、C1-4 烷氧基、亚甲基二氧基、C1-4 烷硫基、C1-4 烷基亚砜、C1-4 烷基砜、CF3、-SO2N(R2)2、NR3R4、吡咯烷基、哌啶基、吗啉基、哌嗪基或 N'- 烷基哌嗪基,R 是氢、C1-4 烷基、C1-4 烷基羰基或苄基;R1、R2、R3 和 R4 各为氢或 C1-4 烷基;及其药学上可接受的盐类。
  • SCHNETTLER, R. A.;DAGE, R. C.;GRISAR, J. M., J. MED. CHEM., 1982, 25, N 12, 1477-1481
    作者:SCHNETTLER, R. A.、DAGE, R. C.、GRISAR, J. M.
    DOI:——
    日期:——
  • US4405635A
    申请人:——
    公开号:US4405635A
    公开(公告)日:1983-09-20
  • 4-Aroyl-1,3-dihydro-2H-imidazol-2-ones, a new class of cardiotonic agents
    作者:Richard A. Schnettler、Richard C. Dage、J. Martin Grisar
    DOI:10.1021/jm00354a017
    日期:1982.12
    A series of 4-aroyl-1,3-dihydro-2H-imidazol-2-ones was synthesized and evaluated for pharmacological activity in the anesthetized dog. Most members of this series produced dose-related increases in cardiac contractile force as well as relatively minor increases in heart rate and decreases in systemic arterial blood pressure that were not blocked by propranolol. In general, 4-methoxy or 4-methylthiobenzoyl substitution afforded compounds of greatest inotropic potency. 1,3-Dihydro-4-(4-methoxybenzoyl)-5-methyl-2H-imidazol-one (6) was shown to produce a dose-related positive inotropic effect and reverse the depressant effect of pentobarbital on cardiac pump function in the dog heart-lung preparation. The cardiotonic activity of this series may have important utility in the treatment of congestive heart failure. 1,3-Dihydro-4-[4-(methylthio)benzoyl]-5-methyl-2H-imidazol-2-one (17) was chosen for human studies and is currently undergoing clinical trials.
查看更多